Navigation Links
First Use in Coronary Patients of a Combined Near-Infrared Spectroscopy and Ultrasound Imaging Catheter
Date:5/19/2009

BURLINGTON, Mass. and ROTTERDAM, Netherlands, May 19 /PRNewswire/ -- InfraReDx, Inc. announced today the first use in patients of a novel coronary catheter that uses both light and sound to image coronary plaques. Working on a team led by Dr. Patrick Serruys, Dr. Martin van der Ent performed the procedures on May 11, 2009 in patients undergoing coronary angiography at the Thoraxcenter.

The combination catheter provides the benefits of both IVUS and NIRS imaging in a single study of the artery. IVUS is a well-established technique that is in common use to quantify the degree of narrowing produced by a plaque, the size of the artery and the adequacy of stent expansion. NIRS is a novel technique recently cleared by the FDA for the identification of lipid core plaques, the structures suspected to cause most heart attacks and complicate stenting procedures.

Prof. Serruys stated that, "The composition of atherosclerotic plaques is important in assessing the likelihood that they will cause cardiovascular events. This novel device provides composition on top of anatomy and will play a pivotal role in interventional cardiology, first in clinical trials and further on in treatment planning in individual patients."

The Biomedical Engineering Department of the Thoraxcenter, led by Prof. Dr. Ton van der Steen, provided expertise essential to the addition of IVUS to the NIRS system.

"In order to determine both composition and structure of an atherosclerotic plaque, a combination catheter is necessary. I am truly excited that InfraReDx teamed up with the Thoraxcenter in this development, both from a technical and a clinical perspective," says Prof. van der Steen.

James E. Muller, M.D., cardiologist, co-founder and CEO of InfraReDx stated that, "The InfraReDx team is proud to have developed the first combined optical and acoustic catheter for use in the coronary arteries of patients. The
'/>"/>

SOURCE InfraReDx, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Cord Blood America to Hold Conference Call on Thursday May 21st at 11 a.m. Eastern Time to Discuss 2009 First Quarter Results and Corporate Developments
2. Physician's Organization Makes History by Publishing U.S.'s First Adult Stem Cell Guidelines (ASCTA Drives Safe Stem Cell Practices)
3. Simcere Pharmaceutical Group Reports Unaudited First Quarter 2009 Results
4. China Biologic Products Announces Strong First Quarter 2009 Results
5. The Institut Pasteur and Merieux Alliance Take First Step Towards a Long-Term Research Partnership in the Field of Infectious Diseases
6. Rodobo International, Inc. Reports Q2 and First Half of 2009
7. China Biologic Products Announces 2009 First Quarter Results Conference Call
8. PharmAthene Reports First Quarter 2009 Financial and Operational Results
9. Tiens Biotech Group (USA) Reports First Quarter Results
10. Spectral announces first quarter 2009 results
11. Oncothyreon reports first quarter 2009 financial results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... VILLAGE, Nev. , July 28, 2015  PDL ... ) today announced that the Company will release its ... June 30, 2015, on Wednesday, August 5, 2015, after ... and webcast that day at 4:30 p.m. Eastern Time ... to the call will be available via the webcast ...
(Date:7/28/2015)... July 21, 2015 ... the addition of the "Analysis of the ... their offering. Globally, flow cytometry remains ... cell proliferation, cancer, and stem cells. But the ... primarily because of demand from underdeveloped nations to ...
(Date:7/28/2015)... , July 28, 2015 Tauriga Sciences, ... diversified life sciences company, today announced that its stockholders ... of common stock of the Company from 1,000,000,000 to ... July 27, 2015 at the Law Offices of Nixon ... the Special Meeting, there were 480,655,929 shares of common ...
(Date:7/28/2015)... KING OF PRUSSIA, Pa. , July 28, 2015 ... the U.S. Food and Drug Administration has accepted for ... novel investigational recombinant factor VIII single-chain (rVIII-SingleChain) for the ... rVIII-SingleChain met all primary endpoints. ... by deficient or defective factor VIII; nearly all affected ...
Breaking Biology Technology:PDL BioPharma to Announce Second Quarter 2015 Financial Results on August 5, 2015 2Analysis of the Global Flow Cytometry Market 2012-2018 with a 2014 Base Year and a 2015-2018 Forecast Period 2Tauriga Sciences, Inc. Stockholders Approve Increase In Authorized Common Stock 2Tauriga Sciences, Inc. Stockholders Approve Increase In Authorized Common Stock 3U.S. FDA Accepts for Review CSL Behring's Biologics License Application for Its Novel rVIII-SingleChain Therapy for Patients with Hemophilia A 2U.S. FDA Accepts for Review CSL Behring's Biologics License Application for Its Novel rVIII-SingleChain Therapy for Patients with Hemophilia A 3
... Ltd. (Amex: CPD ) posted net sales for ... of $108.3 million, as compared to $35.4,million for the ... 206% over the first quarter of Fiscal 2008. Pre-tax ... Fiscal 2009 as compared to a,pre-tax income of $9.6 ...
... Company,s IPLEX(TM) Program in Myotonic ... Muscular Dystrophy, ... of follow-on biologics and biopharmaceuticals, today,announced that Geoffrey Allan, Ph.D., CEO ... of Innovative Therapeutics on,Thursday, August 7th, 2008 at 9:25 AM ET., ...
... 15.7%, ORANGE COUNTY, Calif., July 25 ... developer, manufacturer and marketer,of products that simplify, automate ... and first half ended June 30, 2008,results. Total ... 2007. In constant currency, revenue was up 11.2%. ...
Cached Biology Technology:Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 2Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 3Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 4Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 5Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 6Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 7Insmed CEO to Present at Drug Discovery & Development Conference 2Beckman Coulter Announces Second Quarter 2008 Results 2Beckman Coulter Announces Second Quarter 2008 Results 3Beckman Coulter Announces Second Quarter 2008 Results 4Beckman Coulter Announces Second Quarter 2008 Results 5Beckman Coulter Announces Second Quarter 2008 Results 6Beckman Coulter Announces Second Quarter 2008 Results 7Beckman Coulter Announces Second Quarter 2008 Results 8Beckman Coulter Announces Second Quarter 2008 Results 9Beckman Coulter Announces Second Quarter 2008 Results 10Beckman Coulter Announces Second Quarter 2008 Results 11Beckman Coulter Announces Second Quarter 2008 Results 12Beckman Coulter Announces Second Quarter 2008 Results 13Beckman Coulter Announces Second Quarter 2008 Results 14Beckman Coulter Announces Second Quarter 2008 Results 15Beckman Coulter Announces Second Quarter 2008 Results 16Beckman Coulter Announces Second Quarter 2008 Results 17Beckman Coulter Announces Second Quarter 2008 Results 18Beckman Coulter Announces Second Quarter 2008 Results 19Beckman Coulter Announces Second Quarter 2008 Results 20Beckman Coulter Announces Second Quarter 2008 Results 21Beckman Coulter Announces Second Quarter 2008 Results 22Beckman Coulter Announces Second Quarter 2008 Results 23Beckman Coulter Announces Second Quarter 2008 Results 24Beckman Coulter Announces Second Quarter 2008 Results 25Beckman Coulter Announces Second Quarter 2008 Results 26Beckman Coulter Announces Second Quarter 2008 Results 27Beckman Coulter Announces Second Quarter 2008 Results 28
(Date:7/8/2015)... , July 8, 2015  Trovagene, Inc. ... molecular diagnostics, today announced the launch of a ... Company,s Precision Cancer Monitoring℠ (PCM) technology for predicting ... one or a combination of the novel immunotherapy ... (nivolumab), a PD-1 inhibitor. The 50-patient study will ...
(Date:7/7/2015)... Calif. , July 7, 2015  Based ... market, Frost & Sullivan recognizes Credence ID, LLC ... Entrepreneurial Company of the Year Award. Credence ... to aid in its mission of offering enrollment ... populations globally. As Credence ID was formed by ...
(Date:7/2/2015)... -- Research and Markets( http://www.researchandmarkets.com/research/jvft55/next_generation ) ... Biometrics Market by Application, Technology, Function & Geography - ... The next generation biometrics market is expected ... of 17.9% between 2015 and 2020 Travel ... Safran SA ( France ), ...
Breaking Biology News(10 mins):Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 4Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 2Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 4Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 5Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 2Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 3
... an underwater area with little or no oxygen known commonly ... average, according to a forecast by a team of NOAA-supported ... and the University of Michigan. Scientists are predicting ... or an area roughly the size of the state of ...
... ITHACA, N.Y. Making better solar cells: Cornell ... molecules typically used in blue jean and ink dyes ... to economical, flexible and versatile solar cells. The discovery ... Today,s heavy silicon panels are effective, but they ...
... Institute of Physics (IOP) today, Tuesday 29 June 2010, ... Medal, IOP,s international medal, going to theoretical physicist Professor ... As one of the most influential physicists of the ... ranging from the phenomenology of particle physics and cosmology ...
Cached Biology News:NOAA-supported scientists predict 'larger than average' Gulf dead zone 2Molecules typically found in blue jean and ink dyes may lead to more efficient solar cells 2IOP announces 2010 award winners 2
CQCS kit for first KR 4i , (first unit)....
... Multidrop 384 offers lower consumption of ... screening applications. The Multidrop 384 is ... screening and microvolume dispensing into 384- ... outstanding flexibility. It can easily switch ...
Wellpro 96 an automated liquid handling system for 96-well plates that quickly and accurately prepares large quantities of serial dilutions. The Wellpro also performs plate to plate transfers using ...
... 45° Fixed Angle Rotor ... Centra CL2, Centra CL3CL3R, and ... concentration of sputum samples and ... samples. Provides individual aerosol containment. ...
Biology Products: